Artificial Intelligence Predicts the Pathology and Endoscopic Classification of Colorectal Polyps During Colonoscopy
Led by Peking Union Medical College Hospital · Updated on 2025-01-14
400
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
Brief Title
Who Can Participate
AI-Screening
Your Study Journey
Trial Site Locations
Research Team
How is the study designed?
Similar Trials
Frequently Asked Questions
Research Publications
AI-Summary
What this Trial Is About
Researchers are evaluating the use of artificial intelligence (AI) to predict the pathology and endoscopic classification of colorectal polyps during colonoscopy. Colonoscopy with optical diagnosis based on polyp appearance can guide treatment choices, reduce unnecessary polypectomies, and help plan follow-up, which benefits patients and healthcare systems. However, current classification methods require extensive training and none can accurately diagnose all polyp types, limiting the widespread use of optical diagnosis. AI, specifically computer-aided diagnosis (CADx), has shown promise in identifying small polyps, but its effectiveness for larger polyps (5mm or more) and serrated lesions remains unclear.
CONDITIONS
Brief Title
AI in Predicting Polyp Pathology and Endoscopic Classification
Who Can Participate
Age: 18Years +
All Genders
Healthy Volunteers
Eligibility Criteria
You may qualify if you...
Outpatients or inpatients undergoing routine colonoscopy screening at multicenter hospital endoscopy centers
Aged 18 years or older
Understand the study content and have signed the informed consent form
You will not qualify if you...
Gastroparesis or gastric outlet obstruction
Known or suspected intestinal obstruction or perforation
Severe chronic renal failure (creatinine clearance less than 30 mL/minute)
Severe congestive heart failure (New York Heart Association Class III or IV)
Currently pregnant or breastfeeding
Toxic colitis or megacolon
Poorly controlled hypertension (systolic blood pressure greater than 180 mmHg and/or diastolic blood pressure greater than 100 mmHg)
Moderate or massive active gastrointestinal bleeding (more than 100 mL/day)
Significant psychiatric or psychological illness
Allergy to medications used for bowel preparation
Patients who have undergone colorectal surgery
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Diagnostic Evaluation
Duration - Single day procedure
Participants undergo routine colonoscopy screening during which images of colorectal polyps are captured and analyzed by the AI model to predict pathology and endoscopic classification.
1 visit (in-person)
Long-term Monitoring
Duration - Up to 2 years
Participants are observed for up to 2 years to assess the accuracy and other parameters of the AI model in diagnosing colorectal polyps based on optical diagnosis and endoscopic classification.
Narrow band imaging optical diagnosis of small colorectal polyps in routine clinical practice: the Detect Inspect Characterise Resect and Discard 2 (DISCARD 2) study.
Development and validation of the WASP classification system for optical diagnosis of adenomas, hyperplastic polyps and sessile serrated adenomas/polyps.
Joep E G IJspeert, Barbara A J Bastiaansen, Monique E van Leerdam...
Aim to unify the narrow band imaging (NBI) magnifying classification for colorectal tumors: current status in Japan from a summary of the consensus symposium in the 79th Annual Meeting of the Japan Gastroenterological Endoscopy Society.
ASGE Technology Committee systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting real-time endoscopic assessment of the histology of diminutive colorectal polyps.
ASGE Technology Committee, Barham K Abu Dayyeh, Nirav Thosani...